Physician

Borys Buniak, MD

According to 2025 Medicare claims, Borys Buniak, MD (NPI: 1497747091) practices gastroenterology in the Syracuse, NY market, with the plurality of this provider's patient population coming from Onondaga, NY. This provider's primary affiliated billing organization is GASTROENTEROLOGY & HEPATOLOGY OF CENTRAL NEW YORK, PC (NPI: 1043202641; TIN: 161392177) and primary practice location at 13088-4866. Buniak is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Buniak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,033 traditional Medicare patients, billed 15,085 HCPCS/CPT codes, and received $405,609 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 5,725 prescription claims across 1,207 beneficiaries totaling $2,376,280 in drug costs, led by Stelara (Ustekinumab). DME data shows 199 claims. Open Payments data shows 4 records totaling $908. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $213,585 to $405,609. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,049	2,806	$213,585
2016	1,025	5,544	$244,713
2017	1,091	6,302	$251,184
2018	1,081	6,636	$292,983
2019	1,095	7,406	$307,562
2020	1,130	9,861	$322,518
2021	1,261	13,104	$409,984
2022	1,179	13,515	$378,372
2023	1,022	10,704	$333,176
2024	1,033	15,085	$405,609

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	671	3,672	$3,081,001
2016	725	4,097	$960,838
2017	778	4,198	$1,401,697
2018	752	4,052	$1,256,777
2019	783	4,100	$1,351,401
2020	848	4,043	$1,902,165
2021	850	4,141	$1,826,725
2022	913	4,586	$1,932,301
2023	1,161	5,377	$2,277,220
2024	1,207	5,725	$2,376,280

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	23	$3,847
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	176	$66,836
2023	N/R	208	$84,016
2024	N/R	199	$86,913

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	83	84	$161
45380	Biopsy of large bowel using a flexible endoscope	116	117	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	542	779	$84
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	200	209	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	449	487	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	36	1,722	$937,848
Xifaxan	Rifaximin	58	1,458	$182,069
Linzess	Linaclotide	221	9,298	$163,299
Ocaliva	Obeticholic Acid	18	872	$155,541
Creon	Lipase/Protease/Amylase	135	4,902	$135,339

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4189	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix	N	N/R	49	$71,445
B4224	Parenteral nutrition administration kit, per day	N	N/R	50	$10,054
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	50	$3,279
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	50	$2,136

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$908	Enterra Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Borys Buniak, MD?

Tedicare shows public-source Medicare data for Borys Buniak, MD (NPI 1497747091), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Borys Buniak, MD have ACO affiliation data?

Borys Buniak, MD is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Borys Buniak, MD?

Borys Buniak, MD is linked to GASTROENTEROLOGY & HEPATOLOGY OF CENTRAL NEW YORK, PC (billing NPI 1043202641) in the available physician profile data.

Does Borys Buniak, MD have Open Payments data?

Borys Buniak, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.